SG170065A1 - Human embryonic stem cell methods and podxl expression - Google Patents

Human embryonic stem cell methods and podxl expression

Info

Publication number
SG170065A1
SG170065A1 SG201101522-9A SG2011015229A SG170065A1 SG 170065 A1 SG170065 A1 SG 170065A1 SG 2011015229 A SG2011015229 A SG 2011015229A SG 170065 A1 SG170065 A1 SG 170065A1
Authority
SG
Singapore
Prior art keywords
embryonic stem
human embryonic
cells
stem cell
cell
Prior art date
Application number
SG201101522-9A
Other languages
English (en)
Inventor
Andre Choo
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG170065A1 publication Critical patent/SG170065A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
SG201101522-9A 2006-03-06 2007-03-06 Human embryonic stem cell methods and podxl expression SG170065A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77891306P 2006-03-06 2006-03-06

Publications (1)

Publication Number Publication Date
SG170065A1 true SG170065A1 (en) 2011-04-29

Family

ID=38475152

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201101522-9A SG170065A1 (en) 2006-03-06 2007-03-06 Human embryonic stem cell methods and podxl expression

Country Status (9)

Country Link
US (2) US8173374B2 (fr)
EP (2) EP1994144B1 (fr)
JP (1) JP5507086B2 (fr)
CN (1) CN101454441B (fr)
AU (1) AU2007222165A1 (fr)
CA (1) CA2644856A1 (fr)
IL (1) IL193883A0 (fr)
SG (1) SG170065A1 (fr)
WO (1) WO2007102787A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5507086B2 (ja) 2006-03-06 2014-05-28 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ ヒト胚性幹細胞の方法及びｐｏｄｘｌの発現
WO2009108932A2 (fr) * 2008-02-28 2009-09-03 The Johns Hopkins University Sélection de ligands utiles pour le diagnostic et le traitement du cancer
SG160248A1 (en) * 2008-09-18 2010-04-29 Agency Science Tech & Res Use of novel monoclonal antibodies targeting human embryonic stem cells to characterize and kill induced pluripotent stem cells
WO2010143423A1 (fr) * 2009-06-10 2010-12-16 国立大学法人 新潟大学 Méthode de détection d'une néphropathie diabétique
CA2766164A1 (fr) * 2009-06-25 2010-12-29 Geron Corporation Descendance de cellules souches pluripotentes differenciees appauvrie en phenotypes etrangers
CA2767442A1 (fr) * 2009-07-08 2011-01-13 Actgen Inc. Anticorps ayant une activite anticancereuse
CA2772619C (fr) 2009-09-04 2019-07-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Procede d'amelioration de la stabilite du genome et de l'elongation du telomere dans des cellules souches embryonnaires
EP2315028A1 (fr) 2009-10-26 2011-04-27 Atlas Antibodies AB Protéine PODXL dans le cancer colorectal
WO2011096894A2 (fr) 2010-02-04 2011-08-11 Agency For Science Technology And Research Utilisation de nouveaux marqueurs de cellules souches pluripotentes
WO2012011876A1 (fr) * 2010-07-21 2012-01-26 Agency For Science, Technology And Research Procédés d'identification de molécules d'anticorps cytotoxiques candidates
JP5938726B2 (ja) 2010-10-28 2016-06-22 国立大学法人 熊本大学 多能性幹細胞の分化誘導効率を改善するための方法及び培地
EP2758430A4 (fr) * 2011-09-20 2015-06-03 Lilly Co Eli Anticorps anti-c-met
EP2746768A1 (fr) * 2012-12-20 2014-06-25 Atlas Antibodies AB Podxl dans le cancer de la vessie
US20150344567A1 (en) * 2012-12-21 2015-12-03 The Ritsumeikan Trust iPS/ES CELL-SPECIFIC ANTIBODY HAVING CYTOTOXICITY TO TARGET CELLS AND USE THEREOF
CN103204919B (zh) * 2013-03-29 2014-10-08 浙江大学 胚胎干细胞特异性标志物Aire及其应用
WO2015058301A1 (fr) 2013-10-21 2015-04-30 The Centre For Drug Research And Development Anticorps anti-podocalyxine et leurs méthodes d'utilisation
WO2015084262A2 (fr) * 2013-12-03 2015-06-11 Agency For Science, Technology And Research Anticorps cytotoxique
EP3095864B1 (fr) 2014-01-14 2020-04-15 Kagoshima University Procédé d'étiquetage d'une cellule responsable de la cancérisation dans des cellules souches
US20170335284A1 (en) * 2014-11-07 2017-11-23 Osaka University Differentiation-induced cell population from which undifferentiated cells have been removed, use of same, and method for producing same
US11090383B2 (en) 2015-10-01 2021-08-17 Centre For Drug Research And Development Anti-podocalyxin antibodies and methods of using the same
EP3604503B1 (fr) * 2017-03-28 2026-03-18 Ajinomoto Co., Inc. Additif pour milieu de maintien de dédifférenciation
TWI866945B (zh) * 2018-12-26 2024-12-21 中央研究院 調節萬能性幹細胞之潛能的方法及應用
KR102909979B1 (ko) * 2023-08-02 2026-01-12 세종대학교산학협력단 항 podxl 단일클론항체 및 이의 용도
WO2026164322A1 (fr) * 2025-01-31 2026-08-06 세종대학교산학협력단 Anticorps monoclonal anti-podxl et son utilisation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
HU221001B1 (hu) 1994-03-17 2002-07-29 Merck Patent Gmbh. Egyláncú anti-EGFR Fv-k és anti-EGFR ellenanyagok
GB9717946D0 (en) * 1997-08-22 1997-10-29 Imp Cancer Res Tech Novel chemical entity
KR20010034554A (ko) * 1998-03-03 2001-04-25 레이몬드, 엠. 위티 치료제로서의 ｃｄ147 결합 분자
US7413904B2 (en) * 1998-10-23 2008-08-19 Geron Corporation Human embryonic stem cells having genetic modifications
US20030232430A1 (en) * 2001-11-26 2003-12-18 Advanced Cell Technology Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
US20050281828A1 (en) * 2003-03-04 2005-12-22 Bowdish Katherine S Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
US20030224411A1 (en) * 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
US7833733B2 (en) 2003-06-09 2010-11-16 The University Of British Columbia Methods for detecting and treating cancer
US20050233446A1 (en) 2003-12-31 2005-10-20 Parsons Xuejun H Defined media for stem cell culture
US20060182724A1 (en) * 2005-02-15 2006-08-17 Riordan Neil H Method for expansion of stem cells
EP2206724A1 (fr) 2005-12-13 2010-07-14 Kyoto University Facteur de reprogrammation nucléaire
JP5507086B2 (ja) 2006-03-06 2014-05-28 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ ヒト胚性幹細胞の方法及びｐｏｄｘｌの発現
US20060294607A1 (en) * 2006-03-29 2006-12-28 Applera Corporation Human podocalyxin alternative-spliced forms and uses thereof
WO2007149926A1 (fr) 2006-06-20 2007-12-27 Wisconsin Alumni Research Foundation Procédé de culture de cellules souches
GB2454386B (en) 2006-07-06 2011-07-06 Es Cell Int Pte Ltd Method for embryonic stem cell culture on a positively charged support surface

Also Published As

Publication number Publication date
AU2007222165A1 (en) 2007-09-13
CA2644856A1 (fr) 2007-09-13
EP3275901B1 (fr) 2020-07-15
WO2007102787A1 (fr) 2007-09-13
EP3275901A1 (fr) 2018-01-31
JP2009528838A (ja) 2009-08-13
US20090214490A1 (en) 2009-08-27
EP3275901A8 (fr) 2018-03-21
IL193883A0 (en) 2011-08-01
JP5507086B2 (ja) 2014-05-28
CN101454441B (zh) 2013-06-26
EP1994144A4 (fr) 2009-09-09
EP1994144B1 (fr) 2017-11-22
US8173374B2 (en) 2012-05-08
US20120219962A1 (en) 2012-08-30
CN101454441A (zh) 2009-06-10
US8710190B2 (en) 2014-04-29
EP1994144A1 (fr) 2008-11-26

Similar Documents

Publication Publication Date Title
EP3275901A8 (fr) Procédés de cellules souches embryonnaires humaines et expression podxl
MX2008009886A (es) Anticuerpos que enlazan par-2.
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
WO2006105152A3 (fr) Compositions a base de cellules amniotiques, methodes de production et utilisations desdites compositions
WO2006124641A3 (fr) Anticorps diriges contre la mesotheline utiles pour des dosages immunologiques
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
WO2005047524A3 (fr) Compositions et procedes pour induire la differenciation cellulaire
WO2007084321A3 (fr) Anticorps dirigés contre ox-2/cd200 et utilisations correspondantes
WO2009023331A3 (fr) Anticorps et procédés améliorés de manipulation d'un échantillon test destinés à être utilisés dans des dosages pour myélopéroxidase
SG170080A1 (en) Human monoclonal antibodies to o8e
WO2008118392A3 (fr) Plate-formes synthétiques de cellules et leurs procédés d'utilisation
WO2006089230A3 (fr) Anticorps monoclonaux humains diriges contre l'antigene d'enveloppe specifique de la prostate
GT200800132A (es) Anticuerpos anti-il-23 humanos, composiciones, metodos y usos
EP2534257A4 (fr) Procédés d'identification et d'isolement de cellules exprimant un polypeptide
WO2009126655A3 (fr) Reprogrammation d’une cellule par induction d’un gène pluripotent par utilisation d’un modulateur à petite molécule
WO2008149237A3 (fr) Procédé pour une analyse de méthylation
DE602007011937D1 (de) Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie
WO2006076691A8 (fr) Anticorps 2 associes a la translocation de recepteur immunitaire (irta-2) et leurs utilisations
PL2183599T3 (pl) Wysoko specyficzny test immunologiczny i zestaw do oznaczania peptydów i białek o znaczeniu biologicznym
WO2007114986A3 (fr) Sondes coopératives et leurs procédés d'utilisation
WO2005047860A3 (fr) Anticorps a l'alpha-synucleine
WO2011096894A3 (fr) Utilisation de nouveaux marqueurs de cellules souches pluripotentes
WO2006087220A3 (fr) Récipient pour séparer des cellules tumorales
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
MX2010000979A (es) Metodos y composiciones para tratar enfermedad autoinmune.